Bill Maher Made Adam Schiff and Don Lemon Look Like Morons Last Night
The Nine Lives of Kristi Noem...and She Used Them All Very Quickly
Report: Russia Is Helping Iran Target US Forces
It Must Be Nice Being Married to a Democrat
U.S. Embassy in Norway Targeted by Explosive in New Wave of Attacks on...
Virginia Fraud Ring Allegedly Used Jail Inmates’ Identities to Steal Pandemic Benefits
Illegal Immigrant Arrested for Allegedly Voting in 2024 Pennsylvania Federal Election
Key Iranian Oil Infrastructure Targeted in Latest Operation Epic Fury Strikes
Six U.S. Soldiers Killed in Iran Strike Honored at Dover Air Force Base
FBI: Two Charged in Fraud Ring That Targeted Seniors Across Ohio, Michigan, and...
This New Report Destroys the Leftist Narrative on the Iranian Ship Sinking
Jury Convicts Two Women of Stalking ICE Officer After Livestreamed Pursuit
Southwest Flight Diverted Over Bomb Threat While Democrats Keep DHS Defunded
John Cornyn Announces Support for Ending Silent Filibuster to Pass SAVE America Act
Anti-Communist Protests Erupt in Havana As Trump Eyes Shake-Up in Cuban Leadership
Tipsheet

'Revolving Door': What the WH Left Out of Its Announcement About Nominee for NIH Director

'Revolving Door': What the WH Left Out of Its Announcement About Nominee for NIH Director

President Biden on Monday nominated Dr. Monica Bertagnolli, a surgical oncologist and head of the National Cancer Institute, to be the next director of the National Institutes of Health, but critics say the White House left out an important detail about her background in the administration’s announcement.  

Advertisement

“Dr. Bertagnolli has spent her career pioneering scientific discovery and pushing the boundaries of what is possible to improve cancer prevention and treatment for patients, and ensuring that patients in every community have access to quality care,” Biden said in a statement.
 
“As Director of the National Cancer Institute, Dr. Bertagnolli has advanced my Cancer Moonshot to end cancer as we know it. She has brought together partners and resources from different sectors to launch groundbreaking efforts in cancer prevention and early detection, a national navigation program for childhood cancers, and additional programs to bring clinical trials to more Americans,” the statement continued. “Dr. Bertagnolli is a world-class physician-scientist whose vision and leadership will ensure NIH continues to be an engine of innovation to improve the health of the American people.” 

As Democratic presidential candidate Robert F. Kennedy Jr. and others pointed out, she’s a “revolving door” nominee. 

“From 2015-2021, Bertagnolli received more than 116 grants from Pfizer, totaling $290.8 million. This amount made up 89% of all her. research grants,” he tweeted. 

Kennedy was sure to point out this doesn’t automatically make her “personally corrupt,” but that she will champion Big Pharma’s viewpoints.  

Advertisement

“That is how agencies are captured,” he added, commenting later that he was not surprised the White House left this detail out of the announcement. 


Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement